Culture
Over the last week in February, more than 200 people from psychedelic drug development companies, clinical researchers, regulators, and investors gathered in New Orleans to attend the 6th Annual Psychedelic Therapeutics and Drug Development Conference (PTDD) and the 3rd meeting of the International Society for Psychedelic Research (ISRP).










